Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years'' Follow-up Results of the Greccar-6 Randomized Multicenter Trial. En savoir plus sur Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years'' Follow-up Results of the Greccar-6 Randomized Multicenter Trial.
Inconsistent relationship between body weight/body mass index prior to total knee arthroplasty and the 12-year survival. En savoir plus sur Inconsistent relationship between body weight/body mass index prior to total knee arthroplasty and the 12-year survival.
Three-dimensional image integration guidance for cryoballoon pulmonary vein isolation procedures. En savoir plus sur Three-dimensional image integration guidance for cryoballoon pulmonary vein isolation procedures.
ACL reconstruction in over-50 year-olds: Comparative study between prospective series of over-50 year-old and under-40 year-old patients. En savoir plus sur ACL reconstruction in over-50 year-olds: Comparative study between prospective series of over-50 year-old and under-40 year-old patients.
Outcomes of endoscopic submucosal dissection for early oesophageal squamous cell neoplasia at a Western centre. En savoir plus sur Outcomes of endoscopic submucosal dissection for early oesophageal squamous cell neoplasia at a Western centre.
Laparoscopy for living donor left nephrectomy: Comparison of three-dimensional and two-dimensional vision. En savoir plus sur Laparoscopy for living donor left nephrectomy: Comparison of three-dimensional and two-dimensional vision.
CHIPOFIL: A pilot study assessing the feasibility of HIPEC without extracorporeal circuit. En savoir plus sur CHIPOFIL: A pilot study assessing the feasibility of HIPEC without extracorporeal circuit.
Predictors of Parenchymal Hematoma After Mechanical Thrombectomy: A Multicenter Study En savoir plus sur Predictors of Parenchymal Hematoma After Mechanical Thrombectomy: A Multicenter Study
Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study. En savoir plus sur Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study.